IVRN (IVRN) Stock Price & Analysis
IVRN (IVRN) rose 0.00% to USD 0 as of June 10, 2026 at 09:42 UTC, according to Nexqual real-time market data.
IVRN last closed at USD 0; the session ranged USD 0–0 on volume of 100 shares. Market capitalization is $3,263, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 09:42 UTC.
Key Statistics (as of June 10, 2026 at 09:42 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 100 shares |
| Market Cap | $3,263 |
| Exchange | PNK |
Technical Analysis (IVRN)
Nexqual's technical model rates IVRN "NEUTRAL" based on 2 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 09:42 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (IVRN)
Wall Street analysts rate IVRN "None", per Nexqual as of June 10, 2026 at 09:42 UTC.
| Consensus Rating | None |
|---|
Earnings (IVRN)
Source: Nexqual, June 10, 2026 at 09:42 UTC.
Financials & Fundamentals (IVRN)
| Total Revenue | $0 |
|---|---|
| Gross Margin | +0.00% |
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.08 |
| Total Cash | $543,882 |
| Total Debt | $4.44M |
| Free Cash Flow | $961,618 |
Source: Nexqual, June 10, 2026 at 09:42 UTC.
Financial Health Score (IVRN)
Nexqual rates IVRN's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 09:42 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $544K cash vs $4M debt |
| Cash Flow | Weak — Operating cash flow -$918K |
| Efficiency | Mixed — No data |
Ownership (IVRN)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 4.66M |
| Float | 650,654 |
| Short % of Float | +1.61% |
Source: Nexqual, June 10, 2026 at 09:42 UTC.
Leadership (IVRN)
IVRN is led by Michael W. Yurkowsky (age 53), CEO & Director, per Nexqual as of June 10, 2026 at 09:42 UTC.
| CEO & Director | Michael W. Yurkowsky (age 53) |
|---|---|
| Chief Scientific Officer | Tanya Rhodes (age 64) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EAWD | Energy and Water Development Co | USD 0.01 | ▲ 0% |
| GRMC | GOLDRICH MINING COMPANY | USD 0 | ▲ 0% |
| AABVF | Aberdeen International Inc. | USD 0.02 | ▲ 0% |
| PACV | Pacific Ventures Group Inc. | USD 0 | ▲ 0% |
| AAPJ | AAP, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 09:42 UTC. This page is informational and not investment advice.